HomeNews & TopicsPublic HealthIncreasing access to provincial data on SARS-CoV-2 vaccination in Canada

Increasing access to provincial data on SARS-CoV-2 vaccination in Canada

Public Health

Published on

Kristie Jones

Roadblocks to accessing data on vaccine effectiveness from provincial health ministries impede researchers’ ability to inform a national pandemic response and maintain public trust, according to an analysis in CMAJ (Canadian Medical Association Journal).

Despite recommendations after the SARS outbreak in 2003 to fast-track access to administrative health data to guide pandemic responses, timely access to important data is limited and can limit research abilities.

“Robust COVID-19 clinical data sets, with linkages to patient-level administrative data on vaccination, could be leveraged as clinical trial platforms to prospectively evaluate the safety and effectiveness of vaccines and novel COVID-19 therapies,” writes Dr. Andrew McRae, University of Calgary’s Cumming School of Medicine, with coauthors. “Without linkage to provincially held, patient-level vaccination data, the utility of carefully collected national COVID-19 clinical data sets is substantially constrained.”

In this analysis, authors highlight how health ministries can release data for research while also protecting patients’ privacy. Establishing partnerships between provincial data groups and Health Data Research Network to link data, enable timely data transfer and support research into vaccine effectiveness would be a key step.

“The absence of a coordinated, pan-Canadian, secure research environment for interprovincial data linkage and analysis has been highlighted as a shortcoming in Canadian research infrastructure that has limited the timeliness of Canadian research, both before and during the pandemic,” the authors write.

Provincial health ministries hold COVID-19 vaccination data, but have been reluctant to share it with researchers, limiting researchers’ ability to conduct Canadian vaccine research.

“Making administrative data available to independent researchers presents an important opportunity to validate the effectiveness data for vaccines and build public trust in Canada’s public health and vaccination strategy.”

“Reducing barriers to accessing administrative data on SARS-CoV-2 vaccination for research” is published July 18, 2022.

 

Latest articles

Current Print Issue

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill researchers have developed an AI tool called SIDISH that identifies high-risk cancer cells driving aggressive disease, enabling more precise and targeted treatment strategies. By linking single-cell data with patient outcomes, the tool can predict disease progression and simulate responses to potential drug targets, helping accelerate drug discovery and repurposing. While still in development, SIDISH shows promise for advancing personalized cancer care and improving outcomes across multiple tumour types.
Current Print Issue

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society is urging provinces to lower the colorectal cancer screening age from 50 to 45, citing rising rates among younger adults and evidence that earlier screening could prevent over 15,000 cases and 6,100 deaths. Younger patients are more often diagnosed at advanced stages, making early detection critical. Expanding access to simple screening tools like FIT tests could significantly improve outcomes and save lives.
Current Print Issue

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.
Current Print Issue

Doctors report false health information, lack of health data sharing put patient care at risk

A new CMA survey reveals major risks to patient care in Canada, with 99% of physicians reporting that disconnected health systems limit access to critical patient information and nearly half witnessing serious adverse outcomes as a result. At the same time, 97% of doctors say they have intervened to address harm caused by false or misleading online health information, including AI-generated advice. The findings highlight the urgent need for integrated digital health systems and stronger efforts to promote reliable health information.

More like this

eHealth

Privacy-First AI: How Federated Learning Is Transforming Canadian Cancer Research

Imagine training an AI model on patient data from hospitals in Vancouver, Toronto, and...
Editorial

Healthcare is a human right

Federal government cannot let privatization erode access. Canadians are rightly worried about access to healthcare....
Public Health

Black adults less likely to fill a prescription for medication because of cost

Affordability in Canada is a growing problem, with high costs of food, shelter, medications,...
Technology and Innovation

Home diagnostic tests could cut wait times

HN Summary • At-home diagnostic tests are emerging as a powerful way to ease pressure...
Public Health

How much funding should our governments give hospitals for robust patient care? The dollar amount is not as clear as you’d think.

It’s time Canada had an independent agency – like Australia – that sets targets...
Public Health

Some Ontarians without family doctor at higher risk of death

New research led at the University of Ottawa has found Ontarians without a family...
Load more